Clinical Trial Update: Intranasal Ketamine for Procedural Sedation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating intranasal ketamine for procedural sedation in patients with bone fractures or dislocations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fracture
• Dislocation

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Bone Fractures, Dislocations | Phase 3 | Status: UNKNOWN